You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 10, March 8, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism

Peter A. Singer, MD; David S. Cooper, MD; Elliot G. Levy, MD; Paul W. Ladenson, MD; Lewis E. Braverman, MD; Gilbert Daniels, MD; Francis S. Greenspan, MD; I. Ross McDougall, MB, ChB, PhD; Thomas F. Nikolai, MD

JAMA. 1995;273(10):808-812.


Abstract

Objective.
—To develop a set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with hyperthyroidism and hypothyroidism.

Participants.
—Guidelines were developed by a nine-member ad hoc Standards of Care Committee of the American Thyroid Association (the authors of this article). The participants were selected by the committee chair and the president of the American Thyroid Association on the basis of their clinical experience. The committee members represented different geographic areas within the United States, in order to take into account different practice styles.

Evidence.
—Guidelines were developed on the basis of expert opinion of the participants, as well as on available published information.

Consensus Process.
—Input was obtained from all of the participants, each of whom wrote an initial section of the document. A complete draft document was then written by three participants (P.A.S., D.S.C., and E.G.L.) and resubmitted to the entire committee for revision. The revised document was then submitted to the entire membership of the American Thyroid Association for written comments, which were then reviewed (mainly by P.A.S., D.S.C., and E.G.L.). Many of the suggestions of the American Thyroid Association members were incorporated into the final draft, which was then approved by the Executive Council of the American Thyroid Association. The entire process, from initial drafts to final approval, took approximately 18 months.

Conclusions.
—A set of minimum clinical guidelines for the diagnosis and treatment of hyperthyroidism and hypothyroidism were developed by consensus of a group of experienced thyroidologists. The guidelines are intended to be used by physicians in their care of patients with thyroid disorders, with the expectation that more effective care can be provided, and at a cost savings.

(JAMA. 1995;273:808-812)



Author Affiliations

From the Division of Endocrinology, Diabetes, and Hypertension, University of Southern California School of Medicine, Los Angeles (Dr Singer); Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, Md (Drs Cooper and Ladenson); Division of Endocrinology, Mt Sinai Hospital, Baltimore, Md (Dr Cooper); Division of Endocrinology, University of Miami (Fla) School of Medicine (Dr Levy); Division of Endocrinology, University of Massachusetts Medical School, Worcester (Dr Braverman); Thyroid Unit, Massachusetts General Hospital, Boston (Dr Daniels); Division of Endocrinology, University of California, San Francisco School of Medicine (Dr Greenspan); Division of Nuclear Medicine, Stanford (Calif) University School of Medicine (Dr McDougall); and Marshfield (Wis) Clinic (Dr Nikolai).


Footnotes

Reprint requests to University of Southern California, 1355 S San Pablo St, Room 120, Los Angeles, CA 90033 (Dr Singer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Characteristics of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Caused by Antithyroid Drugs
Noh et al.
J. Clin. Endocrinol. Metab. 2009;94:2806-2811.
ABSTRACT | FULL TEXT  

For Some, L-Thyroxine Replacement Might Not Be Enough: A Genetic Rationale
Kim and Bianco
J. Clin. Endocrinol. Metab. 2009;94:1521-1523.
FULL TEXT  

Thyroid disease in pregnancy
Gajjar et al.
The Obstetrician and Gynaecologist 2009;11:150-151.
FULL TEXT  

Graves' Disease
Brent
NEJM 2008;358:2594-2605.
FULL TEXT  

Treatment of Clinical Hypothyroidism With Thyroxine and Triiodothyronine: A Literature Review and Metaanalysis
Joffe et al.
Psychosomatics 2007;48:379-384.
ABSTRACT | FULL TEXT  

Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis
Lata and Elliott
Nutr Clin Pract 2007;22:261-275.
ABSTRACT | FULL TEXT  

Approach to the Patient with Subclinical Hyperthyroidism
Cooper
J. Clin. Endocrinol. Metab. 2007;92:3-9.
ABSTRACT | FULL TEXT  

Patient Misconceptions and Ethical Challenges in Radioactive Iodine Scanning and Therapy.
Rosenthal
J. Nucl. Med. Technol. 2006;34:143-150.
ABSTRACT | FULL TEXT  

Small Changes in Thyroxine Dosage Do Not Produce Measurable Changes in Hypothyroid Symptoms, Well-Being, or Quality of Life: Results of a Double-Blind, Randomized Clinical Trial
Walsh et al.
J. Clin. Endocrinol. Metab. 2006;91:2624-2630.
ABSTRACT | FULL TEXT  

Levothyroxine Therapy for Hypothyroidism: Should We Abandon Conservative Dosage Titration?
Wartofsky
Arch Intern Med 2005;165:1683-1684.
FULL TEXT  

The Starting Dose of Levothyroxine in Primary Hypothyroidism Treatment: A Prospective, Randomized, Double-blind Trial
Roos et al.
Arch Intern Med 2005;165:1714-1720.
ABSTRACT | FULL TEXT  

Antithyroid Drugs
Cooper
NEJM 2005;352:905-917.
FULL TEXT  

Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society
Gharib et al.
J. Clin. Endocrinol. Metab. 2005;90:581-585.
FULL TEXT  

Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C: A Prospective Cohort Study
Bini and Mehandru
Arch Intern Med 2004;164:2371-2376.
ABSTRACT | FULL TEXT  

Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone
Ebner et al.
Br J Ophthalmol 2004;88:1380-1386.
ABSTRACT | FULL TEXT  

Thyroid Storm During Pregnancy: A Medical Emergency
Waltman et al.
Crit Care Nurse 2004;24:74-79.
FULL TEXT  

Combined T4 and T3 Therapy--Back to the Drawing Board
Cooper
JAMA 2003;290:3002-3004.
FULL TEXT  

Population-based Study of Repeat Laboratory Testing
van Walraven and Raymond
Clin. Chem. 2003;49:1997-2005.
ABSTRACT | FULL TEXT  

Does a Combination Regimen of Thyroxine (T4) and 3,5,3'-Triiodothyronine Improve Depressive Symptoms Better Than T4 Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial
Sawka et al.
J. Clin. Endocrinol. Metab. 2003;88:4551-4555.
ABSTRACT | FULL TEXT  

Indications for Requesting Laboratory Tests for Concurrent Diseases in Patients with Carpal Tunnel Syndrome: A Systematic Review
van Dijk et al.
Clin. Chem. 2003;49:1437-1444.
ABSTRACT | FULL TEXT  

Antithyroid Drugs in the Management of Patients with Graves' Disease: An Evidence-Based Approach to Therapeutic Controversies
Cooper
J. Clin. Endocrinol. Metab. 2003;88:3474-3481.
FULL TEXT  

Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression: Remission and Beyond
Keller
JAMA 2003;289:3152-3160.
ABSTRACT | FULL TEXT  

Effect of High-Dose Liothyronine on Semen Quality and Recovery Following Withdrawal in Rabbits
Foote
J Androl 2002;23:839-844.
ABSTRACT | FULL TEXT  

Arterial Embolization: A Novel Approach to Thyroid Ablative Therapy for Graves' Disease
Xiao et al.
J. Clin. Endocrinol. Metab. 2002;87:3583-3589.
ABSTRACT | FULL TEXT  

Management of patients with thyroid disease: Oral health considerations
PINTO and GLICK
Journal of the American Dental Association 2002;133:849-858.
ABSTRACT | FULL TEXT  

TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study)
Meier et al.
J. Clin. Endocrinol. Metab. 2001;86:4860-4866.
ABSTRACT | FULL TEXT  

Subclinical Hyperthyroidism
Toft
NEJM 2001;345:512-516.
FULL TEXT  

Subclinical Hypothyroidism
Cooper
NEJM 2001;345:260-265.
FULL TEXT  

Graves' Disease
Weetman
NEJM 2000;343:1236-1248.
FULL TEXT  

Update on the Management of Hyperthyroidism and Hypothyroidism
Woeber
Arch Fam Med 2000;9:743-747.
FULL TEXT  

American Thyroid Association Guidelines for Detection of Thyroid Dysfunction
Ladenson et al.
Arch Intern Med 2000;160:1573-1575.
ABSTRACT | FULL TEXT  

Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years
Escobar-Jiménez et al.
Postgrad. Med. J. 2000;76:340-344.
ABSTRACT | FULL TEXT  

Update on the Management of Hyperthyroidism and Hypothyroidism
Woeber
Arch Intern Med 2000;160:1067-1071.
ABSTRACT | FULL TEXT  

Clinical Perspectives in the Diagnosis of Thyroid Disease
Kaplan
Clin. Chem. 1999;45:1377-1383.
ABSTRACT | FULL TEXT  

Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism
Biondi et al.
J. Clin. Endocrinol. Metab. 1999;84:2064-2067.
ABSTRACT | FULL TEXT  

The Effect of Thyroid Hormone on Skeletal Integrity
Greenspan and Greenspan
ANN INTERN MED 1999;130:750-758.
ABSTRACT | FULL TEXT  

Treatment of Benign Nodular Thyroid Disease
Hermus and Huysmans
NEJM 1998;338:1438-1447.
FULL TEXT  

Soluble Ecto-Domain Mutant of Thyrotropin (TSH) Receptor Incapable of Binding TSH Neutralizes the Action of Thyroid-Stimulating Antibodies from Graves' Patients
Osuga et al.
Endocrinology 1998;139:671-676.
ABSTRACT | FULL TEXT  

Outcome of Thyroid Function in Graves' Patients Treated with Radioiodine: Role of Thyroid-Stimulating and Thyrotropin-Blocking Antibodies and of Radioiodine-Induced Thyroid Damage
Chiovato et al.
J. Clin. Endocrinol. Metab. 1998;83:40-46.
ABSTRACT | FULL TEXT  

Increase in Plasma Thyrotropin Levels in Hypothyroid Patients during Treatment due to a Defect in the Commercial Preparation
Peran et al.
J. Clin. Endocrinol. Metab. 1997;82:3192-3195.
ABSTRACT | FULL TEXT  

Bioequivalence of Levothyroxine Preparations for Treatment of Hypothyroidism
Spigelman
JAMA 1997;277:1199-1199.
ABSTRACT  

Bioequivalence of Levothyroxine Preparations for Treatment of Hypothyroidism-Reply
Dong et al.
JAMA 1997;277:1199-1200.
ABSTRACT  

Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism
Vanderpump et al.
BMJ 1996;313:539-544.
FULL TEXT  

Treatment Guidelines for Hyperthyroidism and Hypothyroidism
Ahmad
JAMA 1995;274:1011-1011.
ABSTRACT  

Treatment Guidelines for Hyperthyroidism and Hypothyroidism
Brakke
JAMA 1995;274:1011-1011.
ABSTRACT  

Treatment Guidelines for Hyperthyroidism and Hypothyroidism
Marks
JAMA 1995;274:1011-1011.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.